BMC Cancer
- CUI F, Zhang Y, Tang X, Gong D, et al
Weight gain or loss after diagnosis and survival outcomes in prostate cancer: a
meta-analysis.
BMC Cancer. 2025;25:1286.
BMC Urol
- XIONG J, Liu Y, Qiao X, Ai G, et al
A novel composite index of PSA and periprostatic adipose tissue quantification
for enhancing high-grade prostate cancer prediction.
BMC Urol. 2025;25:199.
Cancer
- SANDERS J, Levell C, Brand LJ, Dahut WL, et al
Consensus-built recommendations to improve prostate cancer outcomes: A summary of
the American Cancer Society Prostate Cancer Collaborative.
Cancer. 2025;131:e70010.
- SAEED F, Berchuck JE, Bilen MA, Gandhi JS, et al
Optimizing treatment for metastatic castration-resistant prostate cancer: Food
and Drug Administration-approved therapies, emerging strategies, and
biomarker-driven approaches.
Cancer. 2025;131:e70037.
Cancer Lett
- GU R, Janknecht J, Oh S, Jiang H, et al
Anti-tumor activity of CDYL2b in prostate cancer.
Cancer Lett. 2025 Aug 12:217987. doi: 10.1016/j.canlet.2025.217987.
- THARIAN L, Verma S, Feinberg D, Parameswaran R, et al
Chimeric Antigen Receptor-Engineered (CAR)-T Cell Therapy for Metastatic Prostate
Cancer.
Cancer Lett. 2025 Aug 12:217986. doi: 10.1016/j.canlet.2025.217986.
Clin Cancer Res
- OWIREDU J, Ersoy-Fazlioglu B, Poluben L, Calagua C, et al
Increased ErbB2 signaling is an early adaptation to androgen signaling inhibition
and persists in castration resistant prostate cancer.
Clin Cancer Res. 2025 Aug 12. doi: 10.1158/1078-0432.CCR-22-3683.
- NAYAK S, Norris JD, Ammirante M, Rychak E, et al
Discovery of BMS-986365, a first-in-class dual androgen receptor ligand-directed
degrader (AR LDD) and antagonist, for the treatment of advanced prostate cancer.
Clin Cancer Res. 2025 Aug 11. doi: 10.1158/1078-0432.CCR-25-0471.
- JIAO J, Ma S, Wu P, Song X, et al
Transrectal Ultrasound-Guided Prostate Biopsy With and Without PSMA PET-Targeted
Prostate Biopsy for Prostate Cancer Diagnosis.
Clin Cancer Res. 2025 Aug 11. doi: 10.1158/1078-0432.CCR-25-0320.
Clin Imaging
- SIMON BD, Harmon SA, Merriman KM, Tetreault J, et al
A multimodal automated deep learning-based model for predicting biochemical
recurrence of prostate cancer following prostatectomy from baseline MRI,
Presurgical clinical covariates.
Clin Imaging. 2025;126:110579.
Clin Med Insights Oncol
- HILIBRAND AS, Tuac Y, Argun O, Breneman CM, et al
Age-Specific Impact of Cribriform Pattern in Prostate Cancer Following Radical
Prostatectomy.
Clin Med Insights Oncol. 2025;19:11795549251363324.
Eur Urol
- MONTORSI F, Barletta F, Gandaglia G, Briganti A, et al
Re: Effect of NeuroSAFE-guided RARP Versus Standard RARP on Erectile Function and
Urinary Continence in Patients with Localised Prostate Cancer (NeuroSAFE PROOF):
A Multicentre, Patient-blinded, Randomised, Controlled Phase 3 Trial.
Eur Urol. 2025 Aug 11:S0302-2838(25)00400-2. doi: 10.1016/j.eururo.2025.
- FAHRNER M, Zamboglou C, Spohn SKB, Oerther B, et al
Advancing Radioproteomics: Integration of Prostate-specific Membrane Antigen
Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic
Resonance Imaging with Localized Proteomic Profiling in Prostate Cancer.
Eur Urol. 2025 Aug 11:S0302-2838(25)00393-8. doi: 10.1016/j.eururo.2025.
- SANTIAGO I, Rivas JG
Re: EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer.
Eur Urol. 2025 Aug 13:S0302-2838(25)00440-3. doi: 10.1016/j.eururo.2025.
Int J Cancer
- HAN Y, Li C, Sun J, Wu G, et al
Comments on "CTHRC1 promotes bone metastasis in prostate cancer".
Int J Cancer. 2025 Aug 8. doi: 10.1002/ijc.70081.
Int J Urol
- ARAI S
Editorial Comment on Preliminary Report on the Efficacy and Safety of Triplet
Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA
Study.
Int J Urol. 2025 Aug 10. doi: 10.1111/iju.70201.
J Magn Reson Imaging
- ESENGUR OT, Stecko H, Stevenson E, Turkbey B, et al
Toward a Refined PI-RADS: The Feasibility and Limitations of More Informative
Metrics in Reviewing MRI Scans.
J Magn Reson Imaging. 2025 Mar 26. doi: 10.1002/jmri.29754.
J Natl Cancer Inst
- QIAN Z, Korn S, Zurl H, Stelzl D, et al
Active surveillance for low-risk prostate cancer: long-term utilization and
outcomes among black men.
J Natl Cancer Inst. 2025 Aug 14:djaf224. doi: 10.1093.
- MAKAROV DV, Thomas JK, Ciprut S, Rivera AJ, et al
Prostate Cancer Imaging Stewardship: a multi-modal, physician-centered
intervention for guideline-concordant imaging.
J Natl Cancer Inst. 2025 Aug 11:djaf210. doi: 10.1093.
J Urol
- JOYCE DD, Siemens DR
Shared Decision-Making in Prostate Cancer Management: Easy to Say, Hard to
Measure.
J Urol. 2025 Aug 14:101097JU0000000000004698. doi: 10.1097/JU.0000000000004698.
- VICKERS A, Touijer K
Letter: Pelvic Lymph Node Dissection in Prostate Cancer: Is It Really Necessary?
A Multicentric Longitudinal Study Assessing Oncological Outcomes in Prostate
Cancer Patients Undergoing Pelvic Lymph Node Dissection vs Radical Prostatectomy
Only.
J Urol. 2025 Aug 12:101097JU0000000000004696. doi: 10.1097/JU.0000000000004696.
Nat Rev Urol
- CONTEDUCA V, Beltran H
State of the art - biomarkers in advanced prostate cancer.
Nat Rev Urol. 2025 Aug 12. doi: 10.1038/s41585-025-01080.
PLoS One
- HAMADA M, Nakata E, Nakahara R, Sugihara S, et al
Risk stratification for the prediction of skeletal-related events in patients
with castration-resistant prostate cancer with bone metastases.
PLoS One. 2025;20:e0328792.
Prostate
- BERTINI A, Stephens A, Finocchiaro A, Vigano S, et al
Mortality and Additional Treatment Rates in Pathologically High-Risk Prostate
Cancer With Prostate-Specific Antigen Persistence at Robot-Assisted Radical
Prostatectomy: Long-Term Report From Single Tertiary Referral Center.
Prostate. 2025 Aug 10. doi: 10.1002/pros.70031.
-
Erratum to "Inhibition of Signaling Downstream of Beta-2 Adrenoceptor by
Propranolol in Prostate Cancer Cells".
Prostate. 2025 Aug 13. doi: 10.1002/pros.70033.
- YILMAZ AB
Letter to the Editor: "Impact of Holmium Laser Enucleation of the Prostate on
Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract
Symptoms".
Prostate. 2025 Aug 13. doi: 10.1002/pros.70012.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016